JP2025504481A5 - - Google Patents
Info
- Publication number
- JP2025504481A5 JP2025504481A5 JP2024543162A JP2024543162A JP2025504481A5 JP 2025504481 A5 JP2025504481 A5 JP 2025504481A5 JP 2024543162 A JP2024543162 A JP 2024543162A JP 2024543162 A JP2024543162 A JP 2024543162A JP 2025504481 A5 JP2025504481 A5 JP 2025504481A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- binds
- pathogen
- immunoglobulin
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263300995P | 2022-01-19 | 2022-01-19 | |
| US63/300,995 | 2022-01-19 | ||
| US202263423667P | 2022-11-08 | 2022-11-08 | |
| US63/423,667 | 2022-11-08 | ||
| PCT/US2023/060893 WO2023141500A2 (en) | 2022-01-19 | 2023-01-19 | Nanobody-drug adducts and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504481A JP2025504481A (ja) | 2025-02-12 |
| JP2025504481A5 true JP2025504481A5 (cg-RX-API-DMAC7.html) | 2026-01-27 |
Family
ID=87349125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543162A Pending JP2025504481A (ja) | 2022-01-19 | 2023-01-19 | ナノボディ－薬物付加物およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250144228A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4466292A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025504481A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240134971A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023209439A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3249160A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL314208A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023141500A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025081106A2 (en) * | 2023-10-12 | 2025-04-17 | Vanderbilt University | Nanobody vaccine compositions |
| WO2025085675A1 (en) * | 2023-10-17 | 2025-04-24 | Mary Lynn Niedrauer | Conjugates, compositions and methods for treating rsv infection |
| WO2026011056A1 (en) | 2024-07-02 | 2026-01-08 | Cerberus Therapeutics | Compositions and methods for improving immune response |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9751945B2 (en) * | 2012-04-13 | 2017-09-05 | Whitehead Institute For Biomedical Research | Sortase-modified VHH domains and uses thereof |
| EP4157883A4 (en) * | 2020-06-02 | 2024-12-04 | Children's Medical Center Corporation | NANOBODY CONJUGATES (VHH) AND THEIR USES |
-
2023
- 2023-01-19 JP JP2024543162A patent/JP2025504481A/ja active Pending
- 2023-01-19 KR KR1020247027127A patent/KR20240134971A/ko active Pending
- 2023-01-19 EP EP23743903.9A patent/EP4466292A2/en active Pending
- 2023-01-19 WO PCT/US2023/060893 patent/WO2023141500A2/en not_active Ceased
- 2023-01-19 IL IL314208A patent/IL314208A/en unknown
- 2023-01-19 AU AU2023209439A patent/AU2023209439A1/en active Pending
- 2023-01-19 US US18/730,142 patent/US20250144228A1/en active Pending
- 2023-01-19 CA CA3249160A patent/CA3249160A1/en active Pending